Literature DB >> 15177841

'It might happen or it might not': how patients with multiple sclerosis explain their perception of prognostic risk.

Hennie R Boeije1, A Cecile J W Janssens.   

Abstract

This qualitative study aimed to examine risk perception and seriousness of wheelchair dependence in patients with multiple sclerosis. Perceived absolute risk and perceived seriousness were assessed for 2-year, 10-year and lifetime prognosis of wheelchair dependence using visual analogue scales (VAS). In semi-structured interviews, patients (n = 85) were asked to elucidate these VAS scores. Explaining perceived absolute risk, patients mentioned disease-related factors as well as psychological factors. Uncertainty about future disease progression was a predominant factor for all patients, even those with low and high perceptions of risk. Wheelchair dependence was perceived as a serious outcome primarily because of its possible implications, such as loss of independence. When perceptions of 2-year, 10-year and the lifetime prospect of wheelchair dependence were compared, it was found that patients discriminated in their perception of absolute risk, but less in that of seriousness. Comparison of quantitative and qualitative assessments indicated good construct validity for perception of the absolute risk and seriousness of wheelchair dependence.

Entities:  

Mesh:

Year:  2004        PMID: 15177841     DOI: 10.1016/j.socscimed.2003.11.040

Source DB:  PubMed          Journal:  Soc Sci Med        ISSN: 0277-9536            Impact factor:   4.634


  8 in total

1.  Intolerance of Uncertainty: Shaping an Agenda for Research on Coping with Multiple Sclerosis.

Authors:  Kevin N Alschuler; Meghan L Beier
Journal:  Int J MS Care       Date:  2015 Jul-Aug

2.  Risk attitudes and risk perceptions in individuals with multiple sclerosis.

Authors:  Bonnie I Glanz; Emily Greeke; Allison LaRussa; Fiona Stuart; David J Rintell; Tanuja Chitnis; Brian C Healy
Journal:  Mult Scler J Exp Transl Clin       Date:  2016-09-02

3.  Risk knowledge of people with relapsing-remitting multiple sclerosis - Results of an international survey.

Authors:  Andrea Giordano; Katrin Liethmann; Sascha Köpke; Jana Poettgen; Anne Christin Rahn; Jelena Drulovic; Yesim Beckmann; Jaume Sastre-Garriga; Ian Galea; Marco Heerings; Peter Joseph Jongen; Eik Vettorazzi; Alessandra Solari; Christoph Heesen
Journal:  PLoS One       Date:  2018-11-29       Impact factor: 3.240

4.  Knowledge Is Power, but Is Ignorance Bliss? Optimising Conversations About Disease Progression in Multiple Sclerosis.

Authors:  Patrick Vermersch; Jane Shanahan; Dawn Langdon; David Yeandle; Nektaria Alexandri; Sven Schippling
Journal:  Neurol Ther       Date:  2019-11-20

5.  Communication, Coordination, and Security for People with Multiple Sclerosis (COCOS-MS): a randomised phase II clinical trial protocol.

Authors:  Heidrun Golla; Kim Dillen; Martin Hellmich; Thomas Dojan; Solveig Ungeheuer; Petra Schmalz; Angelika Staß; Vanessa Mildenberger; Yasemin Goereci; Veronika Dunkl; Julia Strupp; Gereon R Fink; Raymond Voltz; Stephanie Stock; Oliver Cornely; Alexander Stahmann; Anne Müller; Peter Löcherbach; Lothar Burghaus; Volker Limmroth; Eckhard Bonmann; Kathrin Gerbershagen; Gereon Nelles; Thomas Joist; Judith Haas; Herbert Temmes; Clemens Warnke
Journal:  BMJ Open       Date:  2022-01-25       Impact factor: 2.692

6.  Prognostic risk estimates of patients with multiple sclerosis and their physicians: comparison to an online analytical risk counseling tool.

Authors:  Christoph Heesen; Wolfgang Gaissmaier; Franziska Nguyen; Jan-Patrick Stellmann; Jürgen Kasper; Sascha Köpke; Christian Lederer; Anneke Neuhaus; Martin Daumer
Journal:  PLoS One       Date:  2013-05-17       Impact factor: 3.240

7.  A web-based tool for personalized prediction of long-term disease course in patients with multiple sclerosis.

Authors:  I Galea; C Lederer; A Neuhaus; P A Muraro; A Scalfari; N Koch-Henriksen; C Heesen; S Koepke; P Stellmann; H Albrecht; A Winkelmann; F Weber; E Bahn; M Hauser; G Edan; G Ebers; M Daumer
Journal:  Eur J Neurol       Date:  2012-12-07       Impact factor: 6.089

8.  Do people with multiple sclerosis want to know their prognosis? A UK nationwide study.

Authors:  Laura Dennison; Martina Brown; Sarah Kirby; Ian Galea
Journal:  PLoS One       Date:  2018-02-28       Impact factor: 3.752

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.